Paclitaxel plus carboplatin versus standard chemotherapy with either single-agent carboplatin or cyclophosphamide, doxorubicin, and cisplatin in women with ovarian cancer: the ICON3 randomised trial

MKB Parmar, M Adams, M Balestrino, K Bertelsen, C Bonazzi, H Calvert, N Colombo, JF Delaloye, A Durando, D Guthrie, B Hagen, P Harper, C Mangioni, T Perren, Christopher Poole, W Qian, G Rustin, Josie Sandercock, S Tumolo, V TorriF Vecchione

    Research output: Contribution to journalArticle

    466 Citations (Scopus)
    Original languageEnglish
    Pages (from-to)505-515
    Number of pages11
    Issue number9332
    Publication statusPublished - 17 Aug 2002

    Cite this